Physician

Cindy Lynn Lamerson, MD

According to 2025 Medicare claims, Cindy Lamerson, MD (NPI: 1699763201) practices dermatology in the Reno, NV market, with the plurality of this provider's patient population coming from Washoe, NV. This provider's primary affiliated billing organization is NEVADA CENTER FOR DERMATOLOGY (NPI: 1326252131; TIN: 880423605) and primary practice location at 89511-2081.

Lamerson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,256 traditional Medicare patients, billed 6,736 HCPCS/CPT codes, and received $542,828 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 801 prescription claims across 279 beneficiaries totaling $265,548 in drug costs, led by Dupixent Syringe (Dupilumab). Open Payments data shows 85 records totaling $1,984. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $441,668 to $542,828. Similarly, Part D prescription costs have risen steadily, from $67,618 to $265,548. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$350K$701K2015 Medicare payment: $441,668 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $384,424 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $418,984 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $493,702 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $470,244 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $455,881 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $618,505 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $667,996 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $700,579 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $542,828 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20159386,567$441,668
20169005,481$384,424
20179065,395$418,984
20181,0415,713$493,702
20191,0205,345$470,244
20209654,761$455,881
20211,3346,519$618,505
20221,3837,637$667,996
20231,3687,769$700,579
20241,2566,736$542,828

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$276K$552K2015 Drug cost: $67,618 (USD; Tot_Drug_Cst)2016 Drug cost: $135,330 (USD; Tot_Drug_Cst)2017 Drug cost: $202,240 (USD; Tot_Drug_Cst)2018 Drug cost: $247,814 (USD; Tot_Drug_Cst)2019 Drug cost: $250,355 (USD; Tot_Drug_Cst)2020 Drug cost: $255,061 (USD; Tot_Drug_Cst)2021 Drug cost: $421,488 (USD; Tot_Drug_Cst)2022 Drug cost: $552,185 (USD; Tot_Drug_Cst)2023 Drug cost: $335,716 (USD; Tot_Drug_Cst)2024 Drug cost: $265,548 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015259623$67,618
2016269669$135,330
2017319780$202,240
2018306811$247,814
2019346796$250,355
2020292683$255,061
2021329873$421,488
20223931,017$552,185
2023279676$335,716
2024279801$265,548

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more8701,207$75
17110Destruction of skin growth, 1-14 growths263305$74
11102Biopsy of related skin growth, first growth496606$56
17000Destruction of precancer skin growth, 1 growth372442$32
17003Destruction of precancer skin growth, 2-14 growths2791,469$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent SyringeDupilumab311,036$137,649
TacrolimusTacrolimus16454$3,791
KetoconazoleKetoconazole1083,528$2,250
Fluocinolone AcetonideFluocinolone Acetonide23686$1,216
Clobetasol PropionateClobetasol Propionate301,150$1,156

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.85$1,984ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Cindy Lynn Lamerson, MD?

Tedicare shows public-source Medicare data for Cindy Lynn Lamerson, MD (NPI 1699763201), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Cindy Lynn Lamerson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Cindy Lynn Lamerson, MD?

Cindy Lynn Lamerson, MD is linked to NEVADA CENTER FOR DERMATOLOGY (billing NPI 1326252131) in the available physician profile data.

Does Cindy Lynn Lamerson, MD have Open Payments data?

Cindy Lynn Lamerson, MD has 85 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.